Golledge, J., Moran, C.S., Clancy, P., Rush, C., and Norman, P.E. (2010) Use of biomarkers to identify therapy targets and diagnostic markers for abdominal aortic aneurysm. In: Proceedings of the 15th World Congress on Heart Disease. pp. 281-285. From: 15th World Congress on Heart Disease, 24-27 July 2010, Vancouver, Canada.

PDF (Published Version) - Published Version Restricted to Repository staff only

Abstract

Introduction: Abdominal aortic aneurysm (AAA) management is hampered by lack of non-surgical therapies and limited methods to diagnose or predict patients' outcomes.

Methods: A mouse model, human AAA biopsies, cell culture and blood samples were used to identify tissue and blood markers associated with AAA, target potential novel therapies and assess diagnostic and prognostic models.

Results: A number of circulating and tissue biomarkers associated with AAA were identified including osteoprotegerin, osteopontin and D-dimer. A medication stimulating downregulation of osteopontin was able to inhibit aortic dilatation in a mouse model of AAA. A model incorporating plasma D-dimer along with clinical risk factors was able to risk stratify subjects for AAA prevalence and predict AAA expansion.

Conclusions: AAA has a number of tissue and circulating biomarkers which maybe of value in advancing patient management but further validation studies are required.

Item ID:	22698
Item Type:	Conference Item (Presentation)
ISBN:	978-88-7587-617-3
Keywords:	activated receptor-gamma; angiotensin-II; mouse model; osteoprotegerin; association; expression; surveillance; osteopontin; progression; management
Related URLs:	Publisher
Date Deposited:	01 Aug 2012 09:57
FoR Codes:	11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100%
SEO Codes:	92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 100%
Downloads:	Total: 3
	More Statistics